ondansetron has been researched along with AIDS-Associated Lymphoma in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedele, P | 1 |
| Spina, M | 1 |
| Valentini, M | 1 |
| Collini, D | 1 |
| Lucia, C | 1 |
| Manicone, M | 1 |
| Tirelli, U | 1 |
1 trial available for ondansetron and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Lymphoma, AIDS-Related; Lympho | 1995 |